189 related articles for article (PubMed ID: 11750257)
21. Herbal medications in the treatment of benign prostatic hyperplasia (BPH).
Fagelman E; Lowe FC
Urol Clin North Am; 2002 Feb; 29(1):23-9, vii. PubMed ID: 12109350
[TBL] [Abstract][Full Text] [Related]
22. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
[TBL] [Abstract][Full Text] [Related]
23. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
Levin RM; Das AK
Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
[TBL] [Abstract][Full Text] [Related]
24. BPH in 2012: novel agents in treatment of BPH.
Chughtai B; Te A
Nat Rev Urol; 2013 Feb; 10(2):72-3. PubMed ID: 23295239
[No Abstract] [Full Text] [Related]
25. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
[TBL] [Abstract][Full Text] [Related]
26. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
[TBL] [Abstract][Full Text] [Related]
27. [Serenoa repens in benign prostatic hyperplasia].
Log T
Tidsskr Nor Laegeforen; 2008 May; 128(11):1293-4. PubMed ID: 18511974
[TBL] [Abstract][Full Text] [Related]
28. Saw palmetto for BPH symptoms.
Knaus J
Adv Nurse Pract; 2002 Jun; 10(6):26-7. PubMed ID: 12400357
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.
Lopatkin N; Sivkov A; Schläfke S; Funk P; Medvedev A; Engelmann U
Int Urol Nephrol; 2007; 39(4):1137-46. PubMed ID: 18038253
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells.
Scaglione F; Lucini V; Pannacci M; Caronno A; Leone C
Pharmacology; 2008; 82(4):270-5. PubMed ID: 18849646
[TBL] [Abstract][Full Text] [Related]
31. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
[TBL] [Abstract][Full Text] [Related]
32. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
Sharma M; Chadha R; Dhingra N
Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
[TBL] [Abstract][Full Text] [Related]
33. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
34. [The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia].
Pytel' IuA; Lopatkin NA; Gorilovskiĭ LM; Vinarov AZ; Sivkov AV; Medvedev AA
Urologiia; 2004; (2):3-7. PubMed ID: 15114742
[TBL] [Abstract][Full Text] [Related]
35. Plant extracts in BPH.
Di Silverio F; Flammia GP; Sciarra A; Caponera M; Mauro M; Buscarini M; Tavani M; D'Eramo G
Minerva Urol Nefrol; 1993 Dec; 45(4):143-9. PubMed ID: 7517582
[TBL] [Abstract][Full Text] [Related]
36. Saw Palmetto for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
Hammer NC; Thiede J
Am Fam Physician; 2024 May; 109(5):396-397. PubMed ID: 38804752
[No Abstract] [Full Text] [Related]
37. [Phytotherapy for benign prostatic hyperplasia].
Zengerling F
Urologe A; 2018 Jul; 57(7):846-849. PubMed ID: 29876623
[No Abstract] [Full Text] [Related]
38. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
[TBL] [Abstract][Full Text] [Related]
40. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.
Buck AC
J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
